Skip directly to page options Skip directly to A-Z link
Volume 21, Number 7—July 2015
Policy Review

Chronic Q Fever Diagnosis—Consensus Guideline versus Expert Opinion

Linda M. KampschreurComments to Author , Marjolijn C.A. Wegdam-Blans, Peter C. Wever, Nicole H.M. Renders, Corine E. Delsing, Tom Sprong, Marjo E.E. van Kasteren, Henk Bijlmer, Daan Notermans, Jan Jelrik Oosterheert, Frans S. Stals, Marrigje H. Nabuurs-Franssen, Chantal P. Bleeker-Rovers, on behalf of the Dutch Q Fever Consensus Group
Author affiliations: Jeroen Bosch Hospital, ’s-Hertogenbosch, the Netherlands (L.M. Kampschreur, P.C. Wever, N.H.M. Renders); University Medical Center Utrecht, Utrecht, the Netherlands (L.M. Kampschreur, J.J. Oosterheert); Laboratory for Pathology and Medical Microbiology, Veldhoven, the Netherlands (M.C.A. Wegdam-Blans); Radboud University Medical Center, Nijmegen, the Netherlands (C.E. Delsing, C.P. Bleeker-Rovers); Canisius-Wilhelmina Ziekenhuis, Nijmegen (T. Sprong); Canisius-Wilhelmina Ziekenhuis, Nijmegen (T. Sprong, M.H. Nabuurs-Franssen); St. Elisabeth Hospital, Tilburg, the Netherlands (M.E.E. van Kasteren); National Institute for Public Health and the Environment, Bilthoven, the Netherlands (H. Bijlmer, D. Notermans); Atrium Medical Centre, Heerlen, the Netherlands (F.S. Stals)

Main Article

Table 1

Dutch consensus guideline on chronic Q fever diagnostics*

Proven chronic Q fever Probable chronic Q fever Possible chronic Q fever
1. Positive Coxiella burnetii PCR of blood or tissue† IFA ≥1:1,024 for C. burnetii phase I IgG‡ IFA ≥ 1:1,024 for C. burnetii phase I IgG‡ without manifestations meeting the criteria for proven or probable chronic Q fever
OR AND any of the following:
2. IFA ≥1:800 or 1:1,024 for C. burnetii phase I IgG† Valvulopathy not meeting the major criteria of the modified Duke criteria (13)
AND Known aneurysm and/or vascular or cardiac valve prosthesis without signs of infection by means of TEE/ TTE, FDG-PET, CT, MRI, or AUS
Definite endocarditis according to the modified Duke criteria (13)
OR
Proven large vessel or prosthetic infection by imaging studies (FDG-PET, CT, MRI, or AUS) Suspected osteomyelitis or hepatitis as manifestation of chronic Q fever
Pregnancy
Symptoms and signs of chronic infection, such as fever, weight loss and night sweats, hepato-splenomegaly, persistent raised ESR and CRP
Granulomatous tissue inflammation, proven by histological examination
Immunocompromised state

*Source (14). IFA, immunofluorescence assay; TEE, transesophageal echocardiography; TTE, transthoracic echocardiography; FDG-PET, fluorodeoxyglucose positron emission tomography; CT, computed tomography; MRI, magnetic resonance imaging; AUS, abdominal ultrasound; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.
†In the absence of acute infection.
‡Cut-off depends on the IFA technique used, whether in-house developed or commercial.

Main Article

References
  1. Maurin  M, Raoult  D. Q fever. Clin Microbiol Rev. 1999;12:518–53.PubMedGoogle Scholar
  2. van der Hoek  W, Dijkstra  F, Schimmer  B, Schneeberger  PM, Vellema  P, Wijkmans  C, Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill. 2010;15:19520.PubMedGoogle Scholar
  3. Delsing  CE, Kullberg  BJ, Bleeker-Rovers  CP. Q fever in the Netherlands from 2007 to 2010. Neth J Med. 2010;68:382–7.PubMedGoogle Scholar
  4. Landais  C, Fenollar  F, Thuny  F, Raoult  D. From acute Q fever to endocarditis: serological follow-up strategy. Clin Infect Dis. 2007;44:1337–40. DOIPubMedGoogle Scholar
  5. Raoult  D, Tissot-Dupont  H, Foucault  C, Gouvernet  J, Fournier  PE, Bernit  E, Q fever 1985–1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore). 2000;79:109–23. DOIPubMedGoogle Scholar
  6. Botelho-Nevers  E, Fournier  PE, Richet  H, Fenollar  F, Lepidi  H, Foucault  C, Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur J Clin Microbiol Infect Dis. 2007;26:635–40. DOIPubMedGoogle Scholar
  7. Million  M, Thuny  F, Richet  H, Raoult  D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis. 2010;10:527–35. DOIPubMedGoogle Scholar
  8. Raoult  D, Houpikian  P, Tissot  DH, Riss  JM, Arditi-Djiane  J, Brouqui  P. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med. 1999;159:167–73. DOIPubMedGoogle Scholar
  9. Wegdam-Blans  MC, Vainas  T, van Sambeek  MR, Cuypers  PW, Tjhie  HT, van Straten  AH, Vascular complications of Q-fever infections. Eur J Vasc Endovasc Surg. 2011;42:384–92. DOIPubMedGoogle Scholar
  10. Fenollar  F, Fournier  PE, Raoult  D. Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection. J Clin Microbiol. 2004;42:4919–24. DOIPubMedGoogle Scholar
  11. Musso  D, Raoult  D. Coxiella burnetii blood cultures from acute and chronic Q-fever patients. J Clin Microbiol. 1995;33:3129–32.PubMedGoogle Scholar
  12. Dupont  HT, Thirion  X, Raoult  D. Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol. 1994;1:189–96.PubMedGoogle Scholar
  13. Li  JS, Sexton  DJ, Mick  N, Nettles  R, Fowler  VG Jr, Ryan  T, Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8. DOIPubMedGoogle Scholar
  14. Wegdam-Blans  MC, Kampschreur  LM, Delsing  CE, Bleeker-Rovers  CP, Sprong  T, van Kasteren  ME, Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. J Infect. 2012;64:247–59. DOIPubMedGoogle Scholar
  15. Kampschreur  LM, Oosterheert  JJ, Koop  AM, Wegdam-Blans  MC, Delsing  CE, Bleeker-Rovers  CP, Microbiological challenges in the diagnosis of chronic Q fever. Clin Vaccine Immunol. 2012;19:787–90. DOIPubMedGoogle Scholar
  16. Raoult  D. Chronic Q fever: expert opinion versus literature analysis and consensus. J Infect. 2012;65:102–8. DOIPubMedGoogle Scholar

Main Article

1A complete list of the group members is provided at the end of this article.

Page created: June 12, 2015
Page updated: June 12, 2015
Page reviewed: June 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external